# Concentrations of Raltegravir in the Semen of HIV-Infected Men

> **NCT01045265** · — · COMPLETED · sponsor: **Canadian Immunodeficiency Research Collaborative** · enrollment: 16 (actual)

## Conditions studied

- HIV

## Interventions

- **OTHER:** Seminal plasma pharmacokinetics

## Key facts

- **NCT ID:** NCT01045265
- **Lead sponsor:** Canadian Immunodeficiency Research Collaborative
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2009-12
- **Primary completion:** 2011-09
- **Final completion:** 2012-07
- **Target enrollment:** 16 (ACTUAL)
- **Last updated:** 2014-08-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01045265

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01045265, "Concentrations of Raltegravir in the Semen of HIV-Infected Men". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01045265. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*